Trial Profile
Prospective Randomized 12-week Controlled Study Of Visual Field Change In Subjects With Partial Seizures Receiving Pregabalin Or Placebo
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Antiepileptic drugs
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors Pfizer
- 05 Oct 2020 Status changed from recruiting to completed.
- 15 Jun 2020 Planned End Date changed from 11 Sep 2020 to 11 Nov 2020.
- 15 Jun 2020 Planned primary completion date changed from 11 Sep 2020 to 11 Nov 2020.